Display Settings:

Format

Send to:

Choose Destination
    Top HIV Med. 2006 Aug-Sep;14(3):125-30.

    Update of the drug resistance mutations in HIV-1: Fall 2006.

    Source

    Birmingham Veterans Affairs Medical Center and the University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA.

    Abstract

    The International AIDS Society-USA (IAS-USA) Drug Resistance Mutations Group is marking 6 years as an independent volunteer panel of experts focused on identifying key HIV-1 drug resistance mutations. The goal of the effort is to quickly deliver accurate and unbiased information on these mutations to HIV clinical practitioners. This version of the IAS-USA Drug Resistance Mutations Figures replaces the version published in this journal in October/November 2005. The IAS-USA Drug Resistance Mutations Figures are designed for use in identifying mutations associated with viral resistance to antiretroviral drugs and in making therapeutic decisions. Care should be taken when using this list of mutations for surveillance or epidemiologic studies of transmission of drug-resistant virus. A number of amino acid substitutions, particularly minor mutations, represent polymorphisms that in isolation may not reflect prior drug selective pressure or reduced drug susceptibility.

    PMID:
    16946457
    [PubMed - indexed for MEDLINE]
    Free full text

      Supplemental Content

      Icon for IAS-USA

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk